Compugen Ltd (CGEN) is now in the Overvalued zone, suggesting that its current forward PS ratio of 28.39 is considered Overvalued compared with the five-year average of -27.62. The fair price of Compugen Ltd (CGEN) is between 0.85 to 2.11 according to relative valuation method. Compared to the current price of 2.25 USD , Compugen Ltd By Overvalued By 6.73%.

Relative Value

Fair Zone

0.85-2.11

Current Price：2.25

6.73%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Compugen Ltd (CGEN) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Compugen Ltd (CGEN) has a current Price-to-Book (P/B) ratio of 3.31. Compared to its 3-year average P/B ratio of 2.36, the current P/B ratio is approximately 39.95% higher. Relative to its 5-year average P/B ratio of 2.73, the current P/B ratio is about 21.38% higher. Compugen Ltd (CGEN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -2.96%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -5.54%, the current FCF yield is about -100.00% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CGEN competitors is 12.14, providing a benchmark for relative valuation. Compugen Ltd Corp (CGEN.O) exhibits a P/S ratio of 28.39, which is 133.87% above the industry average. Given its robust revenue growth of 4477.29%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CGEN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CGEN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CGEN currently overvalued or undervalued?

What is Compugen Ltd (CGEN) fair value?

CGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Compugen Ltd (CGEN) is between 0.85 to 2.11 according to relative valuation method.

How does CGEN's valuation metrics compare to the industry average?

The average P/S ratio for CGEN's competitors is 12.14, providing a benchmark for relative valuation. Compugen Ltd Corp (CGEN) exhibits a P/S ratio of 28.39, which is 133.87% above the industry average. Given its robust revenue growth of 4477.29%, this premium appears sustainable.

What is the current P/B ratio for Compugen Ltd (CGEN) as of Mar 03 2026?

As of Mar 03 2026, Compugen Ltd (CGEN) has a P/B ratio of 3.31. This indicates that the market values CGEN at 3.31 times its book value.

What is the current FCF Yield for Compugen Ltd (CGEN) as of Mar 03 2026?

As of Mar 03 2026, Compugen Ltd (CGEN) has a FCF Yield of 0.00%. This means that for every dollar of Compugen Ltd's market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Compugen Ltd (CGEN) as of Mar 03 2026?

As of Mar 03 2026, Compugen Ltd (CGEN) has a Forward P/E ratio of -5.04. This means the market is willing to pay $-5.04 for every dollar of Compugen Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Compugen Ltd (CGEN) as of Mar 03 2026?

As of Mar 03 2026, Compugen Ltd (CGEN) has a Forward P/S ratio of 28.39. This means the market is valuing CGEN at $28.39 for every dollar of expected revenue over the next 12 months.

CGEN Valuation